Boston Scientific Corp (BSX)

28.10
NYSE : Health Care
Prev Close 27.86
Day Low/High 27.71 / 28.12
52 Wk Low/High 19.67 / 28.51
Avg Volume 6.88M
Exchange NYSE
Shares Outstanding 1.37B
Market Cap 38.15B
EPS 0.30
P/E Ratio 87.06
Div & Yield N.A. (N.A)

Latest News

Boston Scientific Announces Positive Outcomes From Prospective Study Of Bronchial Thermoplasty

Results from Evaluation of Real-World Patients Presented at American Thoracic Society International Conference

Boston Scientific Closes Symetis Acquisition

Acquisition Expands Company's Structural Heart Portfolio; Increases Offerings for the Treatment of Patients with Valvular Heart Disease

Boston Scientific Announces Positive European Registry Results For WATCHMAN™ Left Atrial Appendage Closure Device

Largest Prospective Study of the WATCHMAN Device Presented as Late-Breaking Trial at Heart Rhythm 2017

Boston Scientific Announces Schedule Of Presentations At EuroPCR 2017

Pivotal Data From REPRISE III and EWOLUTION Among Four Late-breaking Clinical Trials to be Presented

Cramer: These Sectors Look Bullish (Part III)

Cramer: These Sectors Look Bullish (Part III)

From Abbott Labs to Wynn, these names rate checking out.

Boston Scientific Receives U.S. FDA Approval For Resonate™ Family Of High-Voltage Devices

New Devices Combine Longest-Lasting Battery Technology, Therapy Optimization and HeartLogic™ Heart Failure Diagnostics

Cramer: There Are Powerful Themes in Several Bull Markets

Cramer: There Are Powerful Themes in Several Bull Markets

It's a wonder to me how split this market really is.

Boston Scientific Announces Scheduled Presentations At Heart Rhythm Society 2017

Late-Breaking Clinical Trials Feature Subcutaneous Implantable Defibrillator and WATCHMAN™ Left Atrial Appendage Closure Device

S&P 500, Dow Hold Slight Gains as Positive Earnings Counter Oil Slump

S&P 500, Dow Hold Slight Gains as Positive Earnings Counter Oil Slump

Stocks hold onto slight to modest gains Thursday afternoon after positive earnings help to offset a slump in crude oil prices and a decline in energy names.

Stocks Turn Mixed in Face of Crude Oil Slump

Stocks Turn Mixed in Face of Crude Oil Slump

Stocks turn mixed on Thursday after a slump in crude oil prices, and a decline in energy names, snarl earlier upward momentum.

Stock Futures Higher as Positive Earnings Offset Weaker Durable Goods Orders

Stock Futures Higher as Positive Earnings Offset Weaker Durable Goods Orders

Stock futures creep higher on Thursday as Wall Street returns its attention to positive earnings for market direction after a day focused on the White House's tax reform plans.

Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More

Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More

Here are Tuesday's top research calls, including downgrades for Amazon and C.R. Bard, and new coverage of CyrusOne and Dow Chemical.

Boston Scientific's Latest Quant Upgrade Reaffirms a Breakout Ahead

Boston Scientific's Latest Quant Upgrade Reaffirms a Breakout Ahead

A bullish market and another quant upgrade could push BSX past our $31 target.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BSX, RMP, TGEN Downgrades: ESCA, VYGR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Week Ahead: Earnings Come in Thick and Fast in a Middling First-Quarter Reporting Season

Week Ahead: Earnings Come in Thick and Fast in a Middling First-Quarter Reporting Season

Full-steam ahead for earnings season in the coming week as a range of industry leaders across a swath of sectors release their recent quarterly performances.

Boston Scientific Initiates Global Study To Assess Sudden Cardiac Arrest Prevention Therapy In Patients With Diabetes Who Have Previously Experienced A Heart Attack

MADIT S-ICD Trial to Study EMBLEM™ MRI Subcutaneous Implantable Defibrillator (S-ICD) System; Trial Recruitment Part of Pilot Initiative to Increase Percentage of Females Enrolled in Clinical Studies

Canaccord Says Edwards Lifesciences Is Its Favorite Med Tech Stock

Canaccord Says Edwards Lifesciences Is Its Favorite Med Tech Stock

Canaccord is bullish on Edwards Lifescience stock.

IIROC Trade Resumption - BSX

IIROC Trading Halt - BSX

Cramer: These Stocks Look Like 'Easy Pickings'

Cramer: These Stocks Look Like 'Easy Pickings'

From Aetna to United Technologies, these names are hot.

Cramer: The Best Performers Show No Signs of Letting Up

Cramer: The Best Performers Show No Signs of Letting Up

Their overseas business has been carrying them.

Boston Scientific Confirms $435 Million Purchase of Swiss Co. Symetis

Boston Scientific Confirms $435 Million Purchase of Swiss Co. Symetis

Symetis is a structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices.

Boston Scientific Announces Agreement To Acquire Symetis

Acquisition Will Expand Treatments for Patients with Valvular Heart Disease and Strengthen Company's Position in Structural Heart Globally

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ACIW, ACM, BID, CAJ, CHT, GLRE, MBLY, MDXG, UEIC Downgrades: BSX, IAC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

NICE Recommends Boston Scientific CRT-D Devices Powered By EnduraLife™ Battery Technology For Treatment Of Heart Failure

Extended battery life of Boston Scientific devices attributed to reduction in replacement procedures and complications; has potential for significant cost savings

Boston Scientific Receives Favorable Rulings In Edwards Lifesciences Litigation

Edwards Found to Infringe on Boston Scientific Patents in Germany and U.K.